These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6987022)

  • 1. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
    Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
    Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
    George CF; Breckenridge AM; Dollery CT
    Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
    [No Abstract]   [Full Text] [Related]  

  • 7. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spirolactones and potassium-sparing diuretics].
    Thibonnier M; Corvol P; Milliez P
    Rev Prat; 1978 Nov; 28(51):4021-4, 4027-8, 4031-2. PubMed ID: 741188
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiloride in primary hyperaldosteronism.
    Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
    Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
    Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
    Sanguigni D; Benvenuti C
    Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Letter: Potassium retaining diuretics].
    Brummer P
    Duodecim; 1974; 90(23):1691-4. PubMed ID: 4459073
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of spironolactone in hypertensive patients.
    Crane MG; Harris JJ
    Am J Med Sci; 1970 Dec; 260(6):311-30. PubMed ID: 5511395
    [No Abstract]   [Full Text] [Related]  

  • 19. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].
    Meyer P; Milliez P
    Nouv Presse Med; 1972 Sep; 1(32):2121-2. PubMed ID: 5082245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.